Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.

× No keyword cloud information.

10 in total

1. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.

Authors: Marsha A Moses; Jay Harper; Judah Folkman
Journal: N Engl J Med Date: 2006-06-15 Impact factor: 91.245

2. Bevacizumab in hereditary hemorrhagic telangiectasia.

Authors: Prithviraj Bose; Jennifer L Holter; George B Selby
Journal: N Engl J Med Date: 2009-05-14 Impact factor: 91.245

3. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?

Authors: Stella J Bowcock; Hannah E Patrick
Journal: Br J Haematol Date: 2009-05-12 Impact factor: 6.998

4. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.

Authors: Haneen Sadick; Frank Riedel; Ramin Naim; Ulrich Goessler; Karl Hörmann; Mathias Hafner; Andreas Lux
Journal: Haematologica Date: 2005-06 Impact factor: 9.941

5. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia.

Authors: Anna Cirulli; Arcangelo Liso; Francesco D'Ovidio; Anna Mestice; Giovanna Pasculli; Mauro Gallitelli; Rita Rizzi; Giorgina Specchia; Carlo Sabbà
Journal: Acta Haematol Date: 2003 Impact factor: 2.195

6. The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study.

Authors: E M de Gussem; R J Snijder; F J Disch; P Zanen; C J J Westermann; J J Mager
Journal: Rhinology Date: 2009-03 Impact factor: 3.681

7. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Authors: Andrew Mitchell; Leon A Adams; Gerry MacQuillan; Jon Tibballs; Rohan vanden Driesen; Luc Delriviere
Journal: Liver Transpl Date: 2008-02 Impact factor: 5.799

8. Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline.

Authors: Leo C Ginns; David H Roberts; Eugene J Mark; John L Brusch; Jennifer J Marler
Journal: Chest Date: 2003-11 Impact factor: 9.410

Review 9. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Authors: Fatima S Govani; Claire L Shovlin
Journal: Eur J Hum Genet Date: 2009-04-01 Impact factor: 4.246

10. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.

Authors: Jana Simonds; Frank Miller; Jess Mandel; Terence M Davidson
Journal: Laryngoscope Date: 2009-05 Impact factor: 3.325

10 in total